Performance analysis of Viking Therapeutics (VKTX)
Annual Return
Over the past 3 years, VKTX has had an average annual return of +33.40%, outperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, VKTX has had an average annual return of +44.09%, outperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, VKTX has had an average annual return of +39.58%, outperforming the benchmark SPY, which returned +14.95% annual.
Since Apr 29, 2015, VKTX has had an average annual return of +13.29%, underperforming the benchmark SPY, which returned +13.75% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +3.41% | -12.58% | +116.23% | +97.98% | +104.34% | -18.29% | -29.81% | +4.84% | +88.44% | +241.19% | -65.11% | -61.94% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -17.45% | +16.53% | -3.84% | -4.18% | +5% | +19.15% | -6.74% | +3.41% | |||||
| 2025 | -18.61% | -11.85% | -16.35% | +19.55% | -7.17% | -1.12% | +22.90% | -16.95% | -2.85% | +44.90% | -3.33% | -4.43% | -12.58% |
| 2024 | +29.72% | +219.18% | +6.42% | -2.95% | -21.76% | -14.86% | +7.53% | +12.49% | -1.26% | +14.58% | -27.02% | -23.99% | +116.23% |
| 2023 | -6.81% | +25.68% | +51.23% | +27.98% | +3.05% | -26.18% | -10.55% | -4.76% | -19.84% | -11.38% | +24.56% | +52.30% | +97.98% |
| 2022 | -19.34% | -9.71% | -10.46% | -20.67% | -6.70% | +30.15% | +4.16% | +5.66% | -14.45% | +50.72% | -1.22% | +132.10% | +104.34% |
| 2021 | +29.84% | -7.80% | -6.16% | +1.03% | -18.00% | +14.31% | +2.68% | +7.47% | -4.99% | -7.32% | -8.77% | -13.36% | -18.29% |
| 2020 | -21.70% | -5.74% | -20.95% | +23.09% | +24.13% | +0.84% | -2.63% | -4.70% | -13.00% | -3.28% | +14.21% | -12.44% | -29.81% |
| 2019 | +6.66% | +3.06% | +18.20% | -21.23% | -1.79% | +7.92% | -7.34% | -9.62% | -1.01% | -5.96% | +13.14% | +9.56% | +4.84% |
| 2018 | +30.79% | +17.90% | -30.20% | -5.72% | +142.50% | -5.00% | +7.48% | +28.14% | +33.28% | -21.93% | -16.99% | -32.24% | +88.44% |
| 2017 | +18.52% | +8.51% | -4.63% | -4.11% | -15.69% | -8.50% | -2.74% | -0.94% | +83.63% | +24.58% | +27.75% | +33.54% | +241.19% |
Drawdown analysis of Viking Therapeutics (VKTX)
The maximum drawdown for the VKTX was -90.41%, occurring on Aug 2, 2017. Recovery took 208 trading sessions.
The current VKTX drawdown is -61.50%.
Since Apr 29, 2015 VKTX has experienced the following drawdowns:
- 50% or more: 4 times
- 40% or more: 4 times
- 30% or more: 4 times
- 20% or more: 6 times
- 10% or more: 7 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -90.41% | May 6, 2015 | 565 | Aug 2, 2017 | 208 | May 31, 2018 | 773 |
| -89.26% | Sep 19, 2018 | 942 | Jun 16, 2022 | 209 | Apr 18, 2023 | 1151 |
| -78.86% | Feb 28, 2024 | 278 | Apr 8, 2025 | Ongoing | Ongoing | Ongoing |
| -62.72% | Jun 8, 2023 | 98 | Oct 27, 2023 | 70 | Feb 8, 2024 | 168 |
| -25.51% | Jun 15, 2018 | 10 | Jun 29, 2018 | 43 | Aug 30, 2018 | 53 |
| -20.50% | Aug 31, 2018 | 10 | Sep 17, 2018 | 1 | Sep 18, 2018 | 11 |
| -16.25% | May 16, 2023 | 9 | May 30, 2023 | 7 | Jun 8, 2023 | 16 |
| -9.11% | May 31, 2018 | 4 | Jun 6, 2018 | 3 | Jun 11, 2018 | 7 |
| -8.35% | Apr 24, 2023 | 2 | Apr 26, 2023 | 3 | May 1, 2023 | 5 |
| -5.07% | May 1, 2023 | 1 | May 2, 2023 | 3 | May 5, 2023 | 4 |
| -4.02% | May 11, 2023 | 2 | May 15, 2023 | 1 | May 16, 2023 | 3 |
| -3.81% | Apr 19, 2023 | 1 | Apr 20, 2023 | 2 | Apr 24, 2023 | 3 |
| -3.68% | Jun 11, 2018 | 1 | Jun 12, 2018 | 1 | Jun 13, 2018 | 2 |
| -3.54% | Feb 12, 2024 | 1 | Feb 13, 2024 | 1 | Feb 14, 2024 | 2 |
| -2.82% | Feb 16, 2024 | 2 | Feb 21, 2024 | 2 | Feb 23, 2024 | 4 |
| -1.79% | May 5, 2023 | 2 | May 9, 2023 | 2 | May 11, 2023 | 4 |
| -1.79% | Apr 29, 2015 | 1 | Apr 30, 2015 | 1 | May 1, 2015 | 2 |
| -1.18% | Feb 14, 2024 | 1 | Feb 15, 2024 | 1 | Feb 16, 2024 | 2 |